Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lothar Hertle

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|May 9, 2008
The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancerEdwin Herrmann, Eva Stöter, Arndt van Ophoven, et al.
The Journal of Pathology|September 5, 2002
Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urotheliumChristian Steidl, Ronald Simon, Horst Bürger, et al.
Genes, Chromosomes & Cancer|April 3, 2008
Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostateOlaf Bettendorf, Hartmut Schmidt, Annette Staebler, et al.
Journal of Cancer Research and Clinical Oncology|May 12, 2009
Endothelin-A-receptor antagonism with atrasentan exhibits limited activity on the KU-19-19 bladder cancer cell line in a mouse modelEdwin Herrmann, Arne Tiemann, Elke Eltze, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 10, 2011
Combined immunochemotherapy in selected patients with metastatic renal cell carcinoma: HLA class II genotype can help to predict response to therapyStefan Bierer, Ina Hoffmeister, Joachim Gerss, et al.
Anticancer Research|November 1, 2007
VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survivalEdwin Herrmann, Elke Eltze, Stefan Bierer, et al.
Oncology Reports|January 5, 2007
Expression of the Endothelin-axis in the different histologic subtypes of renal cell carcinoma: a tissue microarray analysisEdwin Herrmann, Elke Eltze, Stefan Bierer, et al.
Oncology Reports|June 6, 2007
The role of the endothelin axis and microvessel density in bladder cancer - correlation with tumor angiogenesis and clinical prognosisEdwin Herrmann, Martin Bögemann, Stefan Bierer, et al.
Anticancer Research|July 2, 2010
Negative predictive value of systematic ultrasound-guided prostate biopsy: which tumours do we miss?Thomas Köpke, Frank Oberpenning, Olaf Bettendorf, et al.
European Urology|November 23, 2006
Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracilEdwin Herrmann, Olaf Anselm Brinkmann, Marc-Eric Bode, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Urology : Official Journal of the Japanese Urological Association|May 9, 2008
The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancerEdwin Herrmann, Eva Stöter, Arndt van Ophoven, et al.
The Journal of Pathology|September 5, 2002
Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urotheliumChristian Steidl, Ronald Simon, Horst Bürger, et al.
Genes, Chromosomes & Cancer|April 3, 2008
Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostateOlaf Bettendorf, Hartmut Schmidt, Annette Staebler, et al.
Journal of Cancer Research and Clinical Oncology|May 12, 2009
Endothelin-A-receptor antagonism with atrasentan exhibits limited activity on the KU-19-19 bladder cancer cell line in a mouse modelEdwin Herrmann, Arne Tiemann, Elke Eltze, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 10, 2011
Combined immunochemotherapy in selected patients with metastatic renal cell carcinoma: HLA class II genotype can help to predict response to therapyStefan Bierer, Ina Hoffmeister, Joachim Gerss, et al.
Anticancer Research|November 1, 2007
VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survivalEdwin Herrmann, Elke Eltze, Stefan Bierer, et al.
Oncology Reports|January 5, 2007
Expression of the Endothelin-axis in the different histologic subtypes of renal cell carcinoma: a tissue microarray analysisEdwin Herrmann, Elke Eltze, Stefan Bierer, et al.
Oncology Reports|June 6, 2007
The role of the endothelin axis and microvessel density in bladder cancer - correlation with tumor angiogenesis and clinical prognosisEdwin Herrmann, Martin Bögemann, Stefan Bierer, et al.
Anticancer Research|July 2, 2010
Negative predictive value of systematic ultrasound-guided prostate biopsy: which tumours do we miss?Thomas Köpke, Frank Oberpenning, Olaf Bettendorf, et al.
European Urology|November 23, 2006
Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracilEdwin Herrmann, Olaf Anselm Brinkmann, Marc-Eric Bode, et al.
Pageof 4